Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Drug supplement interactions stories

Oct 7, 2026

GLP-1 weight loss drugs linked to nail detachment and hair loss in new study

A multinational study found that people taking GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound were more than four times as likely to experience nail detachment, along with elevated rates of hair loss and scalp inflammation. Researchers determined that weight loss alone could not fully explain these side effects.

Oct 7, 2026·7 sources
00
May 2, 2026

GLP-1 Drug Semaglutide Reduces Heavy Drinking Days by 50% in Alcohol Use Disorder Trial

A clinical trial of 108 adults with obesity and alcohol use disorder found that once-weekly semaglutide injections reduced heavy drinking days in the past 30 days by an average of roughly 12 days, representing a 50% reduction compared to placebo.

May 2, 2026·1 source
00

Top claims

  • ▪The metabolic health benefits of GLP-1 drugs outweigh their dermatological side effects
  • ▪Lawsuits filed against Novo Nordisk by personal-injury firm Weitz and Luxenberg allege that patients developed non-arteritic anterior ischaemic optic neuropathy while using Ozempic or Wegovy.
  • ▪GLP-1 medications directly cause non-arteritic anterior ischaemic optic neuropathy

Subtopics

Weight management2Addiction & recovery1Addiction and Harm Reduction1Alcohol Use Disorder1Clinical trials1Evidence based supplementation1GLP-1 medications1Health1Lifestyle, Wellness and Nutrition1Longevity & biohacking1Mental Health & Wellbeing1Supplement safety1Weight loss medications & GLP-1 drugs1

Related timelines

Trump administration

161 stories

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Russia-Ukraine war

136 stories